TY  - GEN
AU  - Groen,J V
AU  - Sibinga Mulder,B G
AU  - van Eycken,E
AU  - Valerianova,Z
AU  - Borras,J M
AU  - van der Geest,L G M
AU  - Capretti,G
AU  - Schlesinger-Raab,A
AU  - Primic-Zakelj,M
AU  - Ryzhov,A
AU  - van de Velde,C J H
AU  - Bonsing,B A
AU  - Bastiaannet,E
AU  - Mieog,J S D
TI  - Differences in Treatment and Outcome of Pancreatic Adenocarcinoma Stage I and II in the EURECCA Pancreas Consortium
SN  - 1534-4681
PY  - 2019///0212
KW  - Adenocarcinoma
KW  - mortality
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Chemotherapy, Adjuvant
KW  - Cohort Studies
KW  - Combined Modality Therapy
KW  - Data Collection
KW  - Europe
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoadjuvant Therapy
KW  - Neoplasm Staging
KW  - Pancreatectomy
KW  - Pancreatic Neoplasms
KW  - Survival Rate
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Observational Study
UR  - https://doi.org/10.1245/s10434-018-6705-1
ER  -